A Research Agenda for Malaria Eradication: Monitoring, Evaluation, and Surveillance
Monitoring, evaluation, and surveillance measure how well public health programs operate over time and achieve their goals. As countries approach malaria elimination, these activities will need to shift from measuring reductions in morbidity and mortality, to detecting infections (with or without symptoms) and measuring transmission. Thus, the monitoring and evaluation and surveillance research and development agenda needs to develop the tools and strategies that will replace passive surveillance of morbidity with active and prompt detection of infection, including confirmation of interruption of transmission by detecting present and past infections, particularly in mobile populations. The capacity to assess trends and respond without delay will need to be developed, so that surveillance itself becomes an intervention. Research is also needed to develop sensitive field tests that can detect low levels of parasitaemia, together with strategies for their implementation. Other areas to explore include the rigorous evaluation of the utility of more detailed maps of disease and infection incidence and prevalence, the development of new maps to inform programmatic responses and the use of surveillance technologies based on cell phone or real-time internet Web-based reporting. Because any new strategies for monitoring and evaluation and surveillance for eradication have major implications for program implementation, research is also needed to test systems of delivery for acceptability, feasibility, efficiency, cost-effectiveness, and community engagement. Finally, there is a clear need to systematically review the information from past elimination efforts for malaria and other infectious diseases.
Vyšlo v časopise:
A Research Agenda for Malaria Eradication: Monitoring, Evaluation, and Surveillance. PLoS Med 8(1): e32767. doi:10.1371/journal.pmed.1000400
Kategorie:
Review
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000400
Souhrn
Monitoring, evaluation, and surveillance measure how well public health programs operate over time and achieve their goals. As countries approach malaria elimination, these activities will need to shift from measuring reductions in morbidity and mortality, to detecting infections (with or without symptoms) and measuring transmission. Thus, the monitoring and evaluation and surveillance research and development agenda needs to develop the tools and strategies that will replace passive surveillance of morbidity with active and prompt detection of infection, including confirmation of interruption of transmission by detecting present and past infections, particularly in mobile populations. The capacity to assess trends and respond without delay will need to be developed, so that surveillance itself becomes an intervention. Research is also needed to develop sensitive field tests that can detect low levels of parasitaemia, together with strategies for their implementation. Other areas to explore include the rigorous evaluation of the utility of more detailed maps of disease and infection incidence and prevalence, the development of new maps to inform programmatic responses and the use of surveillance technologies based on cell phone or real-time internet Web-based reporting. Because any new strategies for monitoring and evaluation and surveillance for eradication have major implications for program implementation, research is also needed to test systems of delivery for acceptability, feasibility, efficiency, cost-effectiveness, and community engagement. Finally, there is a clear need to systematically review the information from past elimination efforts for malaria and other infectious diseases.
Zdroje
1. Roll Back Malaria Partnership 2010 Framework for monitoring progress and evaluating outcomes and impact. Available: http://www.rollbackmalaria.org/cmc_upload/0/000/012/168/m_e_en.pdf
2. FeachemRGA
PhillipsAA
TargettGA
2010 Shrinking the malaria map: a prospectus on malaria elimination. Available: http://www.malariaeliminationgroup.org
3. Roll Back Malaria Partnership 2010 The global malaria action plan. Available: http://www.rollbackmalaria.org/gmap/
4. WHO 2008 Global malaria control and elimination: report of a technical review. Geneva World Health Organization Press
5. HopkinsDR
Ruiz-TibenE
DownsP
WithersPCJr
RoyS
2008 Dracunculiasis eradication: neglected no longer. Am J Trop Med Hyg 79 474 479
6. HendersonDA
1999 Lessons from the eradication campaigns. Vaccine 17 S53 S55
7. CochiSL
KewO
2008 Polio today: are we on the verge of global eradication? JAMA 300 839 841
8. BremanJG
QuadrosCA
DowdleWR
FoegeWH
HendersonDA
2011 The role of research in viral disease eradication and elimination programs: Lessons for malaria eradication. PLoS Med 8 e1000405 doi:10.1371/journal.pmed.1000405
9. NájeraJ
González-SilvaM
AlonsoPL
2011 Some lessons for the future from the Global Malaria Eradication Programme (1955–1969). PLoS Med 8 e1000412 doi:10.1371/journal.pmed.1000412
10. AttaH
ZamaniG
2008 The progress of Roll Back Malaria in the Eastern Mediterranean Region over the past decade. East Mediterr Health J 14 S82 S89
11. The malERA Consultative Group on Diagnoses and Diagnostics 2011 A research agenda for malaria eradication: Diagnoses and diagnostics. PLoS Med 8 e1000396 doi:10.1371/journal.pmed.1000396
12. The malERA Consultative Group on Cross-cutting Issues for Eradication 2011 A research agenda for malaria eradication: Cross-cutting issues for eradication. PLoS Med 8 e1000404 doi:10.1371/journal.pmed.1000404
13. PampanaE
1969 A Texbook of malaria eradication. London Oxford University Press
14. HaySI
SmithDL
SnowRW
2008 Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect Dis 8 369 378
15. WHO 1963 Terminology of malaria and malaria eradication: Report of a drafting committee. Geneva WHO
16. YekutielP
1960 Problems of epidemiology in malaria eradication. Bull WHO 22 669 683
17. HarrisI
SharrockWW
BainLM
GrayKA
BobogareA
2010 A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: Challenges for malaria diagnostics in an elimination setting. Malar J 9 254
18. Centers for Disease Control and Prevention, Filler SJ, MacArthur JR, Parise M, Wirtz R, et al. 2006 Locally acquired mosquito-transmitted malaria: A guide for investigations in the United States. MMWR Recomm Rep 55 1 9
19. CeccatoP
ConnorSJ
JeanneI
ThomsonMC
2005 Application of geographical information systems and remote sensing technologies for assessing and monitoring malaria risk. Parassitologia 47 81 96
20. MacauleyC
2005 Aggressive active case detection: A malaria control strategy based on the Brazilian model. Soc Sci Med 60 563 573
21. Betanzos-ReyesAF
RodríguezMH
Duran-ArenasLG
Hernández-AvilaJE
Méndez-GalvánJF
2007 Comparative analysis of two alternative models for epidemiological surveillance in the Mexican Malaria Control program. Health Policy 80 465 482
22. The malERA Consultative Group on Modeling 2011 A research agenda for malaria eradication: Modeling. PLoS Med 8 e1000403 doi:10.1371/journal.pmed.1000403
23. WHO 2007 United Arab Emirates certified malaria-free. Wkly Epidemiol Rec 4 25 32
24. WHO 2007 Guidelines on the elimination of residual foci of malaria transmission. Cairo World Health Organization Regional Office for the Eastern Mediterranean (EMRO). Technical Publications Series 33 Available: http://www.emro.who.int/dsaf/dsa742.pdf
25. The malERA Consultative Group on Drugs 2011 A research agenda for malaria eradication: Drugs. PLoS Med 8 e1000402 doi:10.1371/journal.pmed.1000402
26. PerkinsMD
BellDR
2008 Working without a blindfold: The critical role of diagnostics in malaria control. Malaria J 11 S5
27. BellD
WongsrichanalaiC
BarnwellJW
2006 Ensuring quality and access for malaria diagnosis: how can it be achieved? Nat Rev Microbiol 4 682 695
28. HaySI
GuerraCA
GethingPW
PatilAP
TatemAJ
2009 A world malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med 6 e1000048 doi:10.1371/journal.pmed.1000048
29. HaySI
SnowRW
2006 The Malaria Atlas Project: Developing global maps of malaria risk. PLoS Med 3 e473 doi:10.1371/journal.pmed.0030473
30. NoorAM
MutheuJJ
TatemAJ
HaySI
SnowRW
2009 Insecticide-treated net coverage in Africa: Mapping progress in 2000–07. Lancet 373 58 67
31. SmithDL
HaySI
NoorAM
SnowRW
2009 Predicting changing malaria risk after expanded insecticide-treated net coverage in Africa. Trends Parasitol 25 511 516
32. GaudartJ
PoudiougouB
DickoA
RanqueS
ToureO
2006 Space-time clustering of childhood malaria at the household level: A dynamic cohort in a Mali village. BMC Public Health 6 286
33. RogersDJ
RandolphSE
SnowRW
HaySI
2002 Satellite imagery in the study and forecast of malaria. Nature 7 710 715
34. BlayaJA
FraserHS
HoltB
2010 E-health technologies show promise in developing countries. Health Affairs 29 244 251
35. RandrianasoloL
RaoelinaY
RatsitorahinaM
RavolomananaL
AndriamandimbyS
2010 Sentinel surveillance system for early outbreak detection in Madagascar. BMC Public Health 10 31
36. The malERA Consultative Group on Health Systems and Operational Research 2011 A research agenda for malaria eradication: Health systems and operational research. PLoS Med 8 e1000397 doi:10.1371/journal.pmed.1000397
37. WHO 2009 Methods for surveillance of antimalarial drug efficacy. Geneva World Health Organization
38. The malERA Consultative Group on Vaccines 2011 A research agenda for malaria eradication: Vaccines. PLoS Med 8 e1000398 doi:10.1371/journal.pmed.1000398
39. ButlerJC
BreimanRF
CampbellJF
LipmanHB
BroomeCV
1993 Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA 270 1826 1831
40. CameronAR
BaldockFC
1998 A new probability formula for surveys to substantiate freedom from disease. Prev Vet Med 34 1 17
41. Bruce-ChwattLJ
DodgeJS
DraperCC
TopleyE
VollerA
1972 Sero-epidemiological studies on population groups previously exposed to malaria. Lancet 1 512 515
42. Bruce-ChwattLJ
DraperCC
AvramidisD
KazandzoglouO
1975 Sero-epidemiological surveillance of disappearing malaria in Greece. J Trop Med Hyg 78 194 200
43. DrakeleyC
CookC
2009 Potential contribution of sero-epidemiological analysis for monitoring malaria control and elimination: historical and current perspectives. Adv Parasitol 69 299 352
44. CorranP
ColemanP
RileyE
DrakeleyC
2007 Serology: A robust indicator of malaria transmission intensity? Trends Parasitol 23 575 582
45. TaylorSM
JulianoJJ
TrottmanPA
GriffinJB
LandisSH
2010 High-throughput pooling and real-time PCR-based strategy for malaria detection. J Clin Microbiol 48 512 519
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2011 Číslo 1
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Pleiotropní účinky statinů na kardiovaskulární systém
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- Zástava srdce u pacienta se střelnými ranami – kazuistika
- Statinová intolerance
Najčítanejšie v tomto čísle
- A Research Agenda for Malaria Eradication: Cross-Cutting Issues for Eradication
- The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview
- Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
- Using the Delphi Technique to Determine Which Outcomes to Measure in Clinical Trials: Recommendations for the Future Based on a Systematic Review of Existing Studies